Our Focus

Intellectual Property

Pharma Two B’s investigational products are based on novel formulations of combinations of previously approved drugs. These lead to innovative new products with improvements that provide basis for strong intellectual property protection.

P2B001, a novel low dose investigational combination product for the treatment of Parkinson’s disease, was granted worldwide with claims to composition of matter and use claims.

Additional patents include unique release profiles and other low dose combinations.